Establishment of a functional human immunodeficiency virus type 1 (HIV- 1) reverse transcription complex involves the cytoskeleton

Journal of Experimental Medicine

Volumn 188, Issue 11, 1998, Pages 2113-2125

  Bukrinskaya, Alissa ^a,b   Brichacek, Beda ^a   Mann, Angela ^a   Stevenson, Mario ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

Author keywords

Cytoskeleton; HIV 1 entry; Reverse transcription

Indexed keywords

CELL SURFACE RECEPTOR;

ACTIN FILAMENT; ACTIN MYOSIN INTERACTION; ACTIN POLYMERIZATION; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRION; VIRUS TRANSCRIPTION;

CELL LINE; CYTOSKELETON; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; VIRUS REPLICATION;

EID: 0031775745     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.11.2113     Document Type: Article

References (73)

1. Dragic, T., A. Trkola, and J.P. Moore. 1997. HIV co-receptors: gateways to the cell. In HIV Advances in Research and Therapy. Vol. 7. T.C. Merigan, D.P. Bolognesi, J. Feinberg, P.A. Volberding, and F. Wong-Staal, editors. Cliggott Communications, Greenwich, CT. 3-12.
2. Bukrinsky, M., S. Haggerty, M.P. Dempsey, N. Sharova, A. Adzhubei, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:666-669.
3. Bukrinsky, M.I., N. Sharova, T.L. McDonald, T. Pushkarskaya, W.G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA. 90:6125-6129.
4. Karageorgos, L., P. Li, and C. Burrell. 1993. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retroviruses. 9:817-823.
5. Heinzinger, N., M. Bukrinsky, S. Haggerty, A. Ragland, M.-A. Lee, V. Kewalramani, H. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:7311-7315.
6. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80:379-388.
7. Miller, M.D., C.M. Farnet, and F.D. Bushman. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71: 5382-5390.
8. Farnet, C.M., and W.A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
9. Stevenson, M. 1996. Portals of entry: uncovering HIV nuclear transport pathways. Trends Cell Biol. 6:9-15.
10. Bukrinskaya, A.G., A. Ghorpade, N.K. Heinzinger, T.E. Smithgall, R.E. Lewis, and M. Stevenson. 1996. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:367-371.
11. Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, D. Thines, and M. De Wilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:103-112.
12. Gottlinger, H.G., J.G. Sodroski, and W.A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:5781-5785.
13. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA. 87:523-527.
14. Jacqué, J.-M., A. Mann, H. Enslen, N. Sharova, B. Brichacek, R.J. Davis, and M. Stevenson. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO (Eur. Mol. Biol. Organ.) J. 17:2607-2618.
15. Von Schwedler, U., R.S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA. 91:6992-6996.
16. Freed, E.O., J.M. Orenstein, A.J. Buckler-White, and M.A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
17. Fouchier, R.A., B.E. Meyer, J.H. Simon, U. Fischer, and M.H. Malim. 1997. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO (Eur. Mol. Biol. Organ.) J. 16:4531-4539.
18. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:9825-9830.
19. Vodicka, M.A., D.M. Koepp, P.A. Silver, and M. Emerman. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-185.
20. Nie, Z., D. Bergeron, R.A. Subbramanian, X.J. Yao, F. Checroune, N. Rougeau, and E.A. Cohen. 1998. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol 72:4104-4115.
21. Subbramanian, R.A., A. Kessous-Elbaz, R. Lodge, J. Forget, X.J. Yao, D. Bergeron, and E.A. Cohen. 1998. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187:1103-1111.
22. Subbramanian, R.A., X.J. Yao, H. Dilhuydy, N. Rougeau, D. Bergeron, Y. Robitaille, and E.A. Cohen. 1998. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J. Mol. Biol. 278:13-30.
23. Perotti, M.E., X. Tan, and D.M. Phillips. 1996. Directional budding of human immunodeficiency virus from monocytes. J. Virol 70:5916-5921.
24. Bowerman, B., P.O. Brown, J.M. Bishop, and H.E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
25. Lori, F., V.F. di Marzo, A.L. de Vico, P. Lusso, M.S.J. Reitz, and R.C. Gallo. 1992. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66:5067-5074.
26. Trono, D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-4900.
27. Zhang, H., Y. Zhang, T. Spicer, D. Henrard, and B.J. Poiesz. 1995. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle. J. Virol. 69: 3675-3682.
28. Preston, B.D., B.J. Poiesz, and L.A. Loeb. 1988. Fidelity of HIV-1 reverse transcriptase. Science. 242:1168-1171.
29. Bukrinsky, M.I., N. Sharova, M.P. Dempsey, T.L. Stanwick, A.G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Prof. Natl. Acad. Sci. USA. 89: 6580-6584.
30. Brown, P.O., B. Bowerman, H.E. Varmus, and J.M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell. 49: 347-356.
31. Roe, T., T.C. Reynolds, G. Yu, and P.O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO (Eur. Mol. Biol. Organ.) J. 12:2099-2108.
32. Lewis, P.F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
33. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Prof. Natl. Acad. Sci. USA. 90:8392-8396.
34. ELI. Virology. 185:661-672.
35. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:2232-2239.
36. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70: 2324-2331.
37. Zack, J.A., S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip, and I.S.Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61:213-222.
38. - cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164:280-290.
39. Myers, G., J. Berzofsky, B. Korber, R.F. Smith, and G.N. Pavlakis. 1993. Human retroviruses and AIDS 1993: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, NM.
40. Lochrie, M.A., S. Waugh, D.G. Pratt, Jr., J. Clever, T.G. Parslow, and B. Polisky. 1997. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Adds Res. 25:2902-2910.
41. Geppert, T.D., and P.E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146:3298-3305.
42. Kinch, M.S., J.L. Strominger, and C. Doyle. 1993. Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes. J. Immunol. 151:4552-4561.
43. Miranda, A.F., G.C. Godman, A.D. Deitch, and S.W. Tanenbaum. 1974. Action of cytochalasin D on cells of established lines. I. Early events. J. Cell Biol. 61:481-500.
44. Brown, S.S., and J.A. Spudich. 1981. Mechanism of action of cytochalasin: evidence that it binds to actin filament ends. J. Cell Biol. 88:487-491.
45. Dellagi, K., and J.C. Brouet. 1982. Redistribution of intermediate filaments during capping of lymphocyte surface molecules. Nature. 298:284-286.
46. De Brabander, M.J., R.M. Van de Veire, F.E. Aerts, M. Borgers, and P.A. Janssen. 1976. The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res. 36:905-916.
47. Rey, O., J. Canon, and P. Krogstad. 1996. HIV-1 gag protein associates with F-actin present in microfilaments. Virology. 220:530-534.
48. Coffin, J.M. 1996. Retroviridae: the viruses and their replication. In Fields Virology, 3rd ed. Vol. 2. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman, and S.E. Straus, editors. Lippincott-Raven Publishers, Philadelphia. 1767-1847.
49. Mitchison, T.J., and L.P. Kramer. 1996. Actin-based cell motility and cell locomotion. Cell. 84:371-379.
50. Adelstein, R.S. 1983. Regulation of contractile proteins by phosphorylation. J. Clin. Invest. 72:1863-1866.
51. Wilson, A.K., G. Gorgas, W.D. Claypool, and P. de Lanerolle. 1991. An increase or a decrease in myosin II phosphorylation inhibits macrophage motility. J. Cell Biol. 114:277-283.
52. Jay, P.Y., P.A. Pham, S.A. Wong, and E.L. Elson. 1995. A mechanical function of myosin II in cell motility. J. Cell Sci. 108:387-393.
53. Saitoh, M., T. Ishikawa, S. Matsushima, M. Naka, and H. Hidaka. 1987. Selective inhibition of catalytic activity of smooth muscle myosin light-chain kinase. J. Biol. Chem. 262: 7796-7801.
54. Nakanishi, S., K. Yamada, K. Iwahashi, K. Kuroda, and H. Kase. 1990. KT5926, a potent and selective inhibitor of myosin light-chain kinase. Mol. Pharmacol. 37:482-488.
55. Stein, B.S., S.D. Gowda, J.D. Lifson, R.C. Penhallow, K.G. Bensch, and E.G. Engleman. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 49:659-668.
56. Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:5871-5877.
57. Iyengar, S., J.E.K. Hildreth, and D.H. Schwartz. 1998. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 72: 5251-5255.
58. Moyer, S.A., S.C. Baker, and J.L. Lessard. 1986. Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Prof. Natl. Acad. Sci. USA. 83: 5405-5409.
59. Hill, V.M., and D.F. Summers. 1990. A minor microtubule-associated protein is responsible for the stimulation of vesicular stomatitis virus transcription in vitro. J. Virol. 71:289-298.
60. Huang, Y.T., R.R. Romito, B.P. De, and A.K. Banerjee. 1993. Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology. 193:862-867.
61. De, B.P., A. Lesoon, and A.K. Banerjee. 1991. Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis. J. Virol. 65:3268-3275.
62. De, B.P., A.L. Burdsall, and A.K. Banerjee. 1993. Role of cellular actin in human parainfluenza virus type 3 genome transcription. J. Biol. Chem. 268:5703-5710.
63. Gupta, S., B.P. De, J.A. Drazba, and A.K. Banerjee. 1998. Involvement of actin microfilaments in the replication of human parainfluenza virus type 3. J. Virol. 72:2655-2662.
64. Hottiger, M., K. Gramatikoff, O. Georgiev, C. Chaponnier, W. Schaffner, and U. Hubscher. 1995. The large subunit of HIV-1 reverse transcriptase interacts with beta-actin. Nucleic Acids Res. 23:736-741.
65. Arts, E.J., and M.A. Wainberg. 1996. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv. Virus Res. 46:97-163.
66. Woodard, M.H., W.A. Dunn, R.O. Laine, M. Malandro, R. McMahon, O. Simell, E.R. Block, and M.S. Kilberg. 1994. Plasma membrane clustering of the system y+ (CAT-1) amino acid transporter as detected by immunohistochemistry. Am. J. Physiol. 266:E817-E824.
67. Kizhatil, K., and L.M. Albritton. 1997. Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71:7145-7156.
68. Pearce-Pratt, R., D. Malamud, and D.M. Phillips. 1994. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 68:2898-2905.
69. Sasaki, H., M. Nakamura, T. Ohno, Y. Matsuda, Y. Yuda, and Y. Nonomura. 1995. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. USA. 92:2026-2030.
70. Ott, D.E., L.V. Coren, B.P. Kane, L.K. Busch, D.G. Johnson, R.C. Sowder II, E.N. Chertova, L.O. Arthur, and L.E. Henderson. 1996. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70:7734-7743.
71. Karczewski, M.K., and K. Strebel. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:494-507.
72. Saib, A., F. Puvion-Dutilleul, M. Schmid, J. Peries, and H. de The. 1997. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 71: 1155-1161.
73. Sodeik, B., M.W. Ebersold, and A. Helenius. 1997. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136:1007-1021.